Market Place
Sourcing Support
Tevogen CEO Reaffirms Clinical Commitment Amid Long COVID
11 Mar 2026 //
GLOBENEWSWIRE
Tevogen Aligns Stock Incentives With Revenue Milestones
29 Jan 2026 //
GLOBENEWSWIRE
Tevogen Expands T Cell Pipeline Across Multiple Indications
12 Jan 2026 //
GLOBENEWSWIRE
Tevogen Expands HLA Coverage For Precision T Cell Therapy
05 Nov 2025 //
GLOBENEWSWIRE
Tevogen Enhances TVGN 489 Amid Rising Long COVID Demand
15 Oct 2025 //
GLOBENEWSWIRE
Tevogen Advances AI For T Cell Therapies With 100x Predictcell™
25 Sep 2025 //
GLOBENEWSWIRE
Tevogen Highlights TVGN 489 for Eliminating Long COVID Viral
23 Sep 2025 //
GLOBENEWSWIRE
Tevogen Lauds HHS Efforts on Long COVID, Highlights TVGN 489
19 Sep 2025 //
GLOBENEWSWIRE
Tevogen Values TVGN-489 at $9-$11 B, First Product From Platform
08 Sep 2025 //
GLOBENEWSWIRE
Tevogen Bio Unveils Assets, Plans Valuation Disclosure
27 Aug 2025 //
GLOBENEWSWIRE
Tevogen Honored in BINJE`s BEST 2025 for Health Equity, Biopharma
22 Aug 2025 //
GLOBENEWSWIRE
Tevogen Q2 & H1 2025 Results Show Lower Costs, Growth
19 Aug 2025 //
GLOBENEWSWIRE
Tevogen Bio Raises $50M for R&D and Clinical Development
19 Aug 2025 //
GLOBENEWSWIRE
Tevogen Forecasts $1B Revenue in Launch Year, $10-14B in 5 Years
11 Aug 2025 //
GLOBENEWSWIRE
Tevogen`s institutional ownership surges; 73% of holders boost
06 Aug 2025 //
GLOBENEWSWIRE
Tevogen.AI Expand Microsoft, Databricks Deal for Predictcell Beta
05 Aug 2025 //
GLOBENEWSWIRE
Tevogen Bio to Accept $1 Million Grant for AI Expansion Efforts
01 Aug 2025 //
GLOBENEWSWIRE
Tevogen CEO affirms strong growth, capital position, and AI
01 Aug 2025 //
GLOBENEWSWIRE
Tevogen.AI Gets Global Patent for Immuno AI Technology
18 Jul 2025 //
GLOBENEWSWIRE
Tevogen Signs Intent for New In-House Cell Therapy Manufacturing
17 Jul 2025 //
GLOBENEWSWIRE
Tevogen.AI Eyes Faster Entry via AI Patient Match Post Alpha
16 Jul 2025 //
GLOBENEWSWIRE
Tevogen.AI, Microsoft Launch PredicTcell to Cut R&D Costs
14 Jul 2025 //
GLOBENEWSWIRE
Tevogen.AI Launches With Microsoft, Databricks Support
30 May 2025 //
GLOBENEWSWIRE
Tevogen Bio Secures Own Cell Therapy Production Facility
17 Apr 2025 //
GLOBENEWSWIRE
Tevogen Bio names David E. Banko Global Head of Government Affair
25 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio Develops Unique T Cell Vaccine, Files USPTO Patent
10 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio CIO Mittul Mehta Speaks at Proskauer`s AI Panel
07 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio to Receive $8 M of Non-Dilutive Grant Funding
03 Mar 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Ryan Saadi Named To 2025 NJBIZ Power 100
28 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Talks Short Selling’s Impact On Health
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Shares 2024 Financing On 1-Year Public Listing
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio CEO Commits To Retention Of Equity Capital
14 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio`s Business Model Address Biopharma Industry Challenges
10 Feb 2025 //
GLOBENEWSWIRE
Tevogen Bio Hosts Panels on AI, Health Economics at JP Morgan
26 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio Strengthens IP with AI Patent to T Cell Therapies
19 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio Host Panel on Economics at 43rd J.P. Morgan Conference
17 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio to Attend 43rd J.P. Morgan Healthcare Conference
10 Dec 2024 //
GLOBENEWSWIRE
Dr. Ryan Saadi Commends Public Service & Congratulates Mayor
05 Dec 2024 //
GLOBENEWSWIRE
Tevogen Bio Prepares for Growth Strategy Support
26 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio CEO Reflects on Public Support, Prioritizes Value
21 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Reports Q3 2024 Results, Improves Financial Position
19 Nov 2024 //
GLOBENEWSWIRE
Tevogen Founder Reflects on Preserving Shareholder Value
14 Nov 2024 //
GLOBENEWSWIRE
Tevogen Founder Reflects on Shareholder Value Amid Growth
14 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Nears R&D, Manufacturing Deal & $36M Credit
08 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Partners with Microsoft for HPV Target Identification
05 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio CEO Ryan Saadi Recognized for Business Model
05 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Appoints Anthony Tarantino as Patient Advocate
04 Nov 2024 //
GLOBENEWSWIRE
Tevogen Signs LOI with CD8 for $50M R&D Facility; No Equity Impact
29 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Reports Nasdaq Compliance, CEO Commits to Info Bridge
29 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Provides T Cell Therapy Guidance for Oncology
25 Oct 2024 //
GLOBENEWSWIRE
Tevogen AI Partners with Microsoft for Drug Development
23 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio To Provide Revenue Forecast Timelines This Week
22 Oct 2024 //
GLOBENEWSWIRE
Tevogen Provides Clarity On CSO Share Sales For Tax Obligations
21 Oct 2024 //
GLOBENEWSWIRE
Tevogen Reports Revenue Forecast Of Nearly $1 Billion In Launch Year
21 Oct 2024 //
GLOBENEWSWIRE
Tevogen CEO Thanks Public For Support Of Patient Model.
18 Oct 2024 //
GLOBENEWSWIRE
Tevogen Investors Celebrate Recognition Of Biopharma Model
17 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Forecasts $1B Revenue In Launch Year, $10-14B Over 5
17 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Thanks Warren Township For Honoring CEO Dr. Ryan Saadi
16 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Highlights the Publication of Promising Trial Data
15 Oct 2024 //
GLOBENEWSWIRE
Tevogen Bio Leads in Developing Cell Therapies For HPV In Women
15 Oct 2024 //
GLOBENEWSWIRE
